NeuroXTek – The Swedish Neurotechnology Alliance

Current vision 

Sweden will be a global leader in brain health and mental wellbeing by 2035, driven by a unique cluster of evidence-based, accessible, innovative, and cutting-edge neurotechnologies. These tools—spanning sensing, imaging, stimulation, monitoring, analysis, and modeling—will support research, clinical practice, and home use. 

Background  

Poor mental and brain health are a leading cause of disability, threatening healthcare system and brain economy sustainability. Advancements in neurotechnologies enable improved precision, personalization, quality, scalability, and accessibility. Sweden has strong R&D in neuroscience, physics, engineering, and digital health, but fragmentation and regulatory changes hinder impact. A national initiative is needed to coordinate stakeholders and jointly accelerate transformative solutions. 

Our Network

Alliance members (as of February 25, 2026):

• 173 experts from...
• 20 organizations: Universities, R&D institutes, hospitals/regions,
  SMEs, and large enterprises

Experts' Primary Fields

Thematic working groups

Science, technology, engineering, and math (STEM)

• Neuroscience Needs: Understanding brain health and research challenges.
  Leader: Suzanne Dickson, suzanne.dickson@neuro.gu.se
• Neuroimaging  & Sensing Technologies: Development and integration of sensing and imaging modalities such as MRI, MEG, fNIRS, and advanced data acquisition systems.
  Leader: Daniel Lundqvist, daniel.lundqvist@ki.se
• Clinical Needs: Clinical and patient needs.
  Leader: Isabella Björkman-Burtscher, isabella.bjorkman-burtscher@gu.se>
• Quantum & Disruptive Technologies: Quantum and other next-gen sensing, photonics, and emerging modalities and platforms for brain research and clinical applications.
  Leaders: Mohamed Bourennane, boure@fysik.su.se and
  Erik Aurell, eaurell@kth.se
• Modeling, Compute, & AI: Computational neuroscience, digital twins, machine learning, simulation of brain systems, and brain-inspired computing.
  Leader: William Hedley Thompson, william.thompson@ait.gu.se
• Neurointerfaces & Materials: Bioelectronics, implantable devices, materials science, and neural interface technologies.
  Leader: Maria Asplund, maria.asplund@chalmers.se
• Molecular, Spectroscopic & Biomarker Technologies: Biomarker discovery, spectroscopy, molecular sensing, and translational neurobiology. 
  Leader:  Jerker Widengren, jwideng@kth.se

Social science and humanities (SSH)

• Philosophy of Mind, Cognition, & Human Understanding: Conceptual foundations of neurotechnology, including consciousness, agency, intention, selfhood, mental-state attribution, and the epistemic limits of inference from neural data.
• Ethics, Responsibility, & Societal Implications: Ethical frameworks for neurotechnology, including autonomy, consent, mental privacy, fairness, accountability, responsible R&I, and societal implications across healthcare, work, education, and everyday life.
• Law, Governance, Regulations, & Innovation Management: Compliance and governance relating to MDR, AI Act, data, risk, quality, safety, liability, and standards, together with translation, IPR, user-centered innovation processes, workflow integration, entrepreneurship, and implementation pathways.
• Policy, Inclusion, Societal Engagement, & Strategic Communication: Policy influence and advocacy, inclusion, accessibility, public and stakeholder engagement, trust and legitimacy, and outreach and communication with healthcare, government, industry, civil society, and broader publics.

Steering Committee